Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$30.2K Sell
1,440
-37,978
-96% -$757K 0.02% 344
2022
Q1
$703K Sell
39,418
-15,352
-28% -$284K 0.2% 134
2021
Q4
$1.02M Buy
54,770
+33,897
+162% +$634K 0.25% 91
2021
Q3
$426K Sell
20,873
-12,657
-38% -$266K 0.1% 214
2021
Q2
$716K Sell
33,530
-89,711
-73% -$2.04M 0.16% 123
2021
Q1
$2.82M Sell
123,241
-21,213
-15% -$469K 0.81% 27
2020
Q4
$3.14M Sell
144,454
-10,376
-7% -$224K 0.92% 24
2020
Q3
$3.33M Buy
154,830
+1,660
+1% +$37.1K 0.97% 26
2020
Q2
$3.5M Sell
153,170
-36,002
-19% -$820K 0.93% 24
2020
Q1
$4.16M Buy
189,172
+18,233
+11% +$498K 1.16% 22
2019
Q4
$4.89M Buy
170,939
+61,694
+56% +$1.78M 0.91% 25
2019
Q3
$3.12M Sell
109,245
-3,022
-3% -$80.1K 0.56% 53
2019
Q2
$2.84M Sell
112,267
-59,625
-35% -$1.43M 0.5% 62
2019
Q1
$4.07M Sell
171,892
-261
-0.2% -$6K 0.8% 30
2018
Q4
$3.71M Buy
172,153
+113,148
+192% +$2.63M 0.67% 33
2018
Q3
$1.5M Sell
59,005
-102,135
-63% -$2.5M 0.28% 85
2018
Q2
$3.91M Sell
161,140
-122,494
-43% -$3.07M 0.65% 27
2018
Q1
$7.62M Buy
283,634
+255,367
+903% +$7.11M 1.52% 13
2017
Q4
$830K Buy
+28,267
New +$772K 0.14% 116
2017
Q3
Sell
-9
Closed -$264 642
2017
Q2
$264 Sell
9
-106,114
-100% -$3.13M ﹤0.01% 526
2017
Q1
$3.33M Buy
+106,123
New +$3.34M 0.75% 32
2016
Q3
Sell
-364,060
Closed -$11.5M 653
2016
Q2
$11.9M Buy
+364,060
New +$10.8M 1.96% 20
2016
Q1
Sell
-502,552
Closed -$13.9M 614
2015
Q4
$13.1M Buy
+502,552
New +$12.7M 1.79% 25

Other funds holding T

Exane Derivatives's T Position: Q2 2022 in Review

Exane Derivatives reduced its AT&T (T) stake by 96% in Q2 2022, selling an estimated $757K and leaving 1,440 shares worth $30.2K. The position accounts for 0.02% of the portfolio, ranked #344.

Exane Derivatives first reported a position in T in Q4 2015 and has held it in 23 quarters since. The position peaked at $13.1M in Q4 2015. 2,397 funds tracked by Wall St. Rank hold T as of Q2 2022.

  • Exane Derivatives held 1,440 shares of AT&T worth $30.2K as of Q2 2022.
  • Exane Derivatives sold 37,978 AT&T shares in Q2 2022, an estimated $757K.
  • AT&T made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #344 holding.
  • Exane Derivatives first reported a position in AT&T in Q4 2015 and has held it in 23 quarters since.
  • Exane Derivatives's AT&T position peaked at $13.1M in Q4 2015.
  • 2,397 funds tracked by Wall St. Rank held AT&T as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.